Revitalize HMA
  • Home
  • New HMA Board Members
  • Materials for Shareholders
  • Press
  • FAQ
  • Contact

Back to Press

Glenview Capital Initiates Democratic Process to Elect Eight Industry-Leading Nominees to HMA Board of Directors

June 25, 2013
mac os x snow leopard digital download
Copyright © 2021 Revitalize HMA
Terms of Use
open

Disclaimer

In connection with their solicitation of written consents, Glenview Capital Management, LLC and affiliated persons and entities (“Glenview”) together with the proposed nominees have filed a definitive written consent solicitation statement and accompanying consent card to be used to solicit written consents from stockholders of Health Management Associates, Inc. (“HMA” or “the Company”) with the Securities and Exchange Commission (the “SEC”). Stockholders and other investors are urged to read the definitive written consent solicitation statement and other relevant documents because they contain important information regarding the consent solicitation. The definitive written consent solicitation statement and all other relevant documents are available, free of charge, on the SEC’s website at  www.sec.gov. In addition, Glenview will provide copies of the definitive written consent solicitation statement and accompanying consent card free of charge upon request from Okapi Partners, LLC, 437 Madison Avenue, 28th Floor, New York, NY 10022, (212) 297-0720, Toll Free: (877) 869-0171, or Email: [email protected]com.

The following persons are participants in connection with the written consent solicitation of the shareholders of HMA: Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., Glenview Capital Management, LLC, Larry Robbins and each of the proposed nominees. Information regarding the participants in the consent solicitation and a description of their direct and indirect interests, through security holdings or otherwise, to the extent applicable, is contained in the definitive written consent statement filed with the SEC on July 19, 2013 and is available free of charge on the SEC’s website at www.sec.gov.

Cautionary Statement Regarding Forward-Looking Statements

The content of this website may include “forward-looking statements” that reflect current views of future events. Statements that include the words “expect,” “intend,” “plan,” “believe,” “project,” “anticipate,” “will,” “may,” “would” and similar statements of a future or forward-looking nature are often used to identify forward-looking statements. Similarly, statements that describe our objectives, plans or goals are forward-looking. Glenview’s forward-looking statements are based on its current intent, belief, expectations, estimates and projections regarding the Company and projections regarding the industry in which it operates. These statements are not guarantees of future performance and involve risks, uncertainties, assumptions and other factors that are difficult to predict and that could cause actual results to differ materially. Accordingly, you should not rely upon forward-looking statements as a prediction of actual results and actual results may vary materially from what is expressed in or indicated by the forward-looking statements. Except to the extent required by applicable law, no person undertakes any obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments or otherwise.

Enter Site

I confirm that I have read the terms of this website.